As of 2026-05-11, the Relative Valuation of CVS Health Corp (CVS) is 63.48 USD. This relative valuation is based on P/E multiples. With the latest stock price at 90.55 USD, the upside of CVS Health Corp based on Relative Valuation is -29.9%.
The range of the Relative Valuation is 25.41 - 105.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 22.9x | 21.2x |
| Forward P/E multiples | 14.4x - 19.0x | 17.6x |
| Fair Price | 25.41 - 105.94 | 63.48 |
| Upside | -71.9% - 17.0% | -29.9% |
| Date | P/E |
| 2026-05-08 | 65.64 |
| 2026-05-07 | 63.33 |
| 2026-05-06 | 62.96 |
| 2026-05-05 | 58.49 |
| 2026-05-04 | 59.45 |
| 2026-05-01 | 59.51 |
| 2026-04-30 | 60.38 |
| 2026-04-29 | 60.82 |
| 2026-04-28 | 58.70 |
| 2026-04-27 | 56.80 |
| 2026-04-24 | 56.50 |
| 2026-04-23 | 57.16 |
| 2026-04-22 | 55.40 |
| 2026-04-21 | 56.08 |
| 2026-04-20 | 55.51 |
| 2026-04-17 | 56.03 |
| 2026-04-16 | 55.66 |
| 2026-04-15 | 54.36 |
| 2026-04-14 | 56.27 |
| 2026-04-13 | 56.61 |
| 2026-04-10 | 57.51 |
| 2026-04-09 | 57.15 |
| 2026-04-08 | 57.11 |
| 2026-04-07 | 56.70 |
| 2026-04-06 | 53.12 |
| 2026-04-02 | 53.27 |
| 2026-04-01 | 52.55 |
| 2026-03-31 | 52.06 |
| 2026-03-30 | 50.84 |
| 2026-03-27 | 50.80 |
| 2026-03-26 | 51.60 |
| 2026-03-25 | 52.32 |
| 2026-03-24 | 52.77 |
| 2026-03-23 | 51.68 |
| 2026-03-20 | 51.81 |
| 2026-03-19 | 52.09 |
| 2026-03-18 | 52.93 |
| 2026-03-17 | 54.23 |
| 2026-03-16 | 54.98 |
| 2026-03-13 | 55.19 |
| 2026-03-12 | 55.14 |
| 2026-03-11 | 54.89 |
| 2026-03-10 | 55.32 |
| 2026-03-09 | 56.73 |
| 2026-03-06 | 56.48 |
| 2026-03-05 | 57.04 |
| 2026-03-04 | 58.40 |
| 2026-03-03 | 58.35 |
| 2026-03-02 | 59.19 |
| 2026-02-27 | 57.92 |